These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37337672)

  • 1. Response to the letter to the editor-'Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline' by Jafari et al.
    Brørs G; Gjeilo KH; Mjølstad OC
    Eur J Cardiovasc Nurs; 2023 Dec; 22(8):e135-e136. PubMed ID: 37337672
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor: 'Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline'.
    Jafari H; Shafipour V; Kamali M; Mollaei A
    Eur J Cardiovasc Nurs; 2023 Dec; 22(8):e133-e134. PubMed ID: 37337657
    [No Abstract]   [Full Text] [Related]  

  • 3. The incidence of phlebitis with intravenous amiodarone at guideline dose recommendations.
    Slim AM; Roth JE; Duffy B; Boyd SY; Rubal BJ
    Mil Med; 2007 Dec; 172(12):1279-83. PubMed ID: 18274029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral amiodarone-related phlebitis: an institutional nursing guideline to reduce patient harm.
    Spiering M
    J Infus Nurs; 2014; 37(6):453-60. PubMed ID: 25376322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phlebitis in Intravenous Amiodarone Administration: Incidence and Contributing Factors.
    Oragano CA; Patton D; Moore Z
    Crit Care Nurse; 2019 Feb; 39(1):e1-e12. PubMed ID: 30710042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline.
    Brørs G; Gjeilo KH; Lund T; Skevik K; Aa E; Høvik LH; Skarsvaag T; Mjølstad OC
    Eur J Cardiovasc Nurs; 2023 Dec; 22(8):824-831. PubMed ID: 36594941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phlebitis in amiodarone administration: incidence, contributing factors, and clinical implications.
    Norton L; Ottoboni LK; Varady A; Yang-Lu CY; Becker N; Cotter T; Pummer E; Haynes A; Forsey L; Matsuda K; Wang P
    Am J Crit Care; 2013 Nov; 22(6):498-505. PubMed ID: 24186821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral Phlebitis Related to Amiodarone Infusion.
    Hannibal GB
    AACN Adv Crit Care; 2016 Oct; 27(4):465-471. PubMed ID: 27959304
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone.
    Boyce BA; Yee BH
    Crit Care Nurse; 2012 Aug; 32(4):27-34. PubMed ID: 22855076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of injection-site splinting on the incidence of phlebitis in patients taking peripherally infused amiodarone: A randomized clinical trial.
    Ayat-Isfahani F; Pashang M; Davoudi B; Sadeghian S; Jalali A
    J Vasc Nurs; 2017 Mar; 35(1):31-35. PubMed ID: 28224950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone-induced phlebitis remains an issue in spite of measures to reduce its occurrence.
    Dixon HA; Hort AL; Wright CM
    J Vasc Access; 2019 Nov; 20(6):786-787. PubMed ID: 30958088
    [No Abstract]   [Full Text] [Related]  

  • 12. Reducing the Incidence of Amiodarone-related Phlebitis Through Utilization of Evidence-based Practice.
    Murphy K; Murphy J; Fischer-Cartlidge E
    Worldviews Evid Based Nurs; 2020 Oct; 17(5):385-392. PubMed ID: 33047461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of topical chamomile on the incidence of phlebitis due to an amiodarone infusion in coronary care patients: a double-blind, randomized controlled trial.
    Sharifi-Ardani M; Yekefallah L; Asefzadeh S; Nassiri-Asl M
    J Integr Med; 2017 Sep; 15(5):373-378. PubMed ID: 28844214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies in phlebitis. IV: Injection rate and amiodarone-induced phlebitis.
    Ward GH; Yalkowsky SH
    J Parenter Sci Technol; 1993; 47(1):40-3. PubMed ID: 8445500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.
    Hilleman DE; Spinler SA
    Pharmacotherapy; 2002 Jan; 22(1):66-74. PubMed ID: 11794432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies in phlebitis. II. Early detection of amiodarone-induced phlebitis in a rabbit model.
    Ward GH; Nolan PE; White M; Yalkowsky SH
    Pharm Res; 1991 Jun; 8(6):801-3. PubMed ID: 2062813
    [No Abstract]   [Full Text] [Related]  

  • 17. Amiodarone-induced infusion phlebitis.
    Hilleman DE; Hansen JM; Mohiuddin SM
    Clin Pharm; 1987 May; 6(5):364, 367. PubMed ID: 3665388
    [No Abstract]   [Full Text] [Related]  

  • 18. Adherence to guidelines in monitoring amiodarone-induced thyroid dysfunction.
    Huang CJ; Tseng CL; Chu CH; Huang DF; Huang CC; Lin LY
    J Eval Clin Pract; 2017 Feb; 23(1):108-113. PubMed ID: 27515316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies in phlebitis. VI: Dilution-induced precipitation of amiodarone HCL.
    Ward GH; Yalkowsky SH
    J Parenter Sci Technol; 1993; 47(4):161-5. PubMed ID: 8410561
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravascular thrombophlebitis related to the peripheral infusion of amiodarone and vancomycin.
    Mowry JL; Hartman LS
    West J Nurs Res; 2011 Apr; 33(3):457-71. PubMed ID: 20947794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.